Literature DB >> 3934854

Variability in the expression of xenobiotic-metabolizing enzymes during the growth cycle of rat hepatoma cells.

G Krupski, F Kiefer, F J Wiebel.   

Abstract

The activity of various xenobiotic-metabolizing enzymes was examined throughout the growth cycle (16d) of the well-differentiated rat hepatoma cell line C2Rev7. Cytochrome P-450-dependent aldrin epoxidase activity showed a peak on day 3 after plating of cells and decreased by more than 90% during the following six days. Glutathione S-transferase and UDP-glucuronosyl transferase with 4-hydroxybiphenyl as substrate also showed decreases in their activities towards the later phase of the growth cycle, although to lesser extents than the mono-oxygenase. The activity of cytochrome c reductase and of the UDP-glucuronosyl transferase with 3-hydroxybenzo[a]pyrene as substrate remained constant throughout the growth cycle. Aldrin epoxidase activities varied markedly with the number of cells plated. The results suggest that the balance of activating and inactivating pathways may vary considerably during the growth cycle of differentiated hepatoma cells. This should be taken into account when standardizing these cells as test systems for the assessment of cytotoxic and genotoxic chemicals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934854     DOI: 10.3109/00498258509047441

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data.

Authors:  L T Baxter; R K Jain
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

2.  AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo.

Authors:  S R McKeown; M V Hejmadi; I A McIntyre; J J McAleer; L H Patterson
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

3.  DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.

Authors:  M V Hejmadi; S R McKeown; O P Friery; I A McIntyre; L H Patterson; D G Hirst
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.